Health Care Stocks Held by Hedge Funds
All health care-sector stocks held by tracked institutional funds per the latest SEC 13F filings, sorted by number of fund holders.
CYH
Community Health Systems
1.61
-13.44%
122Funds Holding
$131.28MInstitutional value
-67vs last quarter
INBX
Inhibrx Biosciences
74.33
+7.63%
122Funds Holding
$887.83MInstitutional value
-51vs last quarter
RCKT
Rocket Pharmaceuticals
2.11
+0.00%
122Funds Holding
$162.48MInstitutional value
-68vs last quarter
VMD
Viemed Healthcare
8.61
-1.94%
122Funds Holding
$172.63MInstitutional value
-52vs last quarter
RAPP
Rapport Therapeutics
23.59
+0.81%
121Funds Holding
$852.20MInstitutional value
-47vs last quarter
ACRS
Aclaris Therapeutics
3.50
+0.00%
120Funds Holding
$404.79MInstitutional value
-37vs last quarter
ARCT
Arcturus Therapeutics Holdings
7.60
-5.47%
120Funds Holding
$285.40MInstitutional value
-22vs last quarter
SIGA
Siga Technologies
2.65
-5.36%
120Funds Holding
$83.34MInstitutional value
-50vs last quarter
ELDN
Eledon Pharmaceuticals
1.90
-6.40%
119Funds Holding
$62.89MInstitutional value
-50vs last quarter
BCAX
Bicara Therapeutics
9.12
-2.77%
118Funds Holding
$606.31MInstitutional value
-66vs last quarter
GPCR
Structure Therapeutics
17.12
-1.38%
118Funds Holding
$1.01BInstitutional value
-85vs last quarter
ABCL
Abcellera Biologics
10.47
-4.99%
117Funds Holding
$978.75MInstitutional value
-39vs last quarter
NUS
Nu Skin Enterprises
3.77
-2.58%
117Funds Holding
$112.90MInstitutional value
-53vs last quarter
SVRA
Savara
5.21
+10.38%
117Funds Holding
$446.67MInstitutional value
-71vs last quarter
FDMT
4D Molecular
10.72
+2.49%
116Funds Holding
$285.55MInstitutional value
-51vs last quarter
LXRX
Lexicon Pharmaceuticals
1.67
-2.91%
116Funds Holding
$647.07MInstitutional value
-41vs last quarter
PHAT
Phathom Pharmaceuticals
5.08
-4.15%
116Funds Holding
$306.82MInstitutional value
-55vs last quarter
SEPN
Septerna
39.20
-0.63%
116Funds Holding
$523.72MInstitutional value
-51vs last quarter
OCGN
Ocugen
0.73
-0.87%
115Funds Holding
$103.48MInstitutional value
-41vs last quarter
ZBIO
Zenas Biopharma
25.04
-5.22%
114Funds Holding
$1.21BInstitutional value
-48vs last quarter
CADL
Candel Therapeutics
5.13
-3.57%
113Funds Holding
$358.72MInstitutional value
-33vs last quarter
MLTX
Moonlake Immunotherapeutics
11.03
+2.22%
113Funds Holding
$247.65MInstitutional value
-66vs last quarter
AVIR
Atea Pharmaceuticals
3.93
-1.50%
112Funds Holding
$263.34MInstitutional value
-20vs last quarter
CRBU
Caribou Biosciences
0.31
-4.78%
112Funds Holding
$52.88MInstitutional value
-29vs last quarter
VSTM
Verastem
6.86
-0.15%
112Funds Holding
$343.97MInstitutional value
-55vs last quarter
BIOA
BioAge Labs
4.71
-1.26%
111Funds Holding
$131.27MInstitutional value
-46vs last quarter
CAPR
Capricor Therapeutics
7.53
-6.23%
111Funds Holding
$201.60MInstitutional value
-73vs last quarter
LCTX
Lineage Cell Therapeutics in
0.82
-2.21%
111Funds Holding
$55.18MInstitutional value
-25vs last quarter
STVN
Stevanato Group
15.93
+3.71%
109Funds Holding
$889.63MInstitutional value
-22vs last quarter
BBNX
Beta Bionics
13.32
-7.05%
107Funds Holding
$767.69MInstitutional value
-38vs last quarter
CABA
Cabaletta Bio
1.01
-4.27%
106Funds Holding
$133.89MInstitutional value
-46vs last quarter
JBIO
Jade Biosciences
15.06
-2.78%
106Funds Holding
$540.67MInstitutional value
-56vs last quarter
CHRS
Coherus Oncology
0.39
-5.56%
105Funds Holding
$66.13MInstitutional value
-48vs last quarter
FATE
Fate Therapeutics
1.01
-3.81%
105Funds Holding
$95.51MInstitutional value
-57vs last quarter
TYRA
Tyra Biosciences
19.73
+0.61%
105Funds Holding
$688.95MInstitutional value
-70vs last quarter
VOR
Vor Biopharma
18.52
+3.87%
105Funds Holding
$459.75MInstitutional value
-3vs last quarter
HUMA
Humacyte
0.54
+8.50%
104Funds Holding
$23.31MInstitutional value
-71vs last quarter
OSUR
Orasure Technologies
3.61
+0.56%
104Funds Holding
$163.73MInstitutional value
-54vs last quarter
PLSE
Pulse Biosciences
44.41
-3.10%
104Funds Holding
$504.56MInstitutional value
-11vs last quarter
SLDB
Solid Biosciences
6.44
+1.42%
104Funds Holding
$352.32MInstitutional value
-60vs last quarter
AURA
Aura Biosciences
6.98
-2.24%
103Funds Holding
$202.13MInstitutional value
-54vs last quarter
DCTH
Delcath Systems
19.24
-2.34%
103Funds Holding
$209.22MInstitutional value
-29vs last quarter
LRMR
Larimar Therapeutics
3.22
-0.16%
103Funds Holding
$127.96MInstitutional value
-64vs last quarter
MMED
Minimed Group
16.26
-4.30%
103Funds Holding
$723.25MInstitutional value
-2vs last quarter
FULC
Fulcrum Therapeutics
3.71
-0.27%
102Funds Holding
$166.57MInstitutional value
-61vs last quarter
IMRX
Immuneering
3.45
-1.43%
102Funds Holding
$133.65MInstitutional value
-17vs last quarter
INGN
Inogen
5.42
-2.69%
102Funds Holding
$63.35MInstitutional value
-30vs last quarter
LXEO
Lexeo Therapeutics
2.95
+0.00%
102Funds Holding
$144.98MInstitutional value
-49vs last quarter
ANIK
Anika Therapeutics
13.28
-2.50%
101Funds Holding
$155.97MInstitutional value
-37vs last quarter
AVBP
Arrivent Biopharma
11.26
+3.30%
101Funds Holding
$581.42MInstitutional value
-64vs last quarter
1036 stocks in Health Care · prices as of 2026-11-19